Daily Courier: Single Column

Why Vaxxinity Stock Is Not a Buy After the IPO

Vaxxinity stock appeared on Robinhood IPO Access last week. This biotechnology company expects an IPO on November 11, and will trade on the Nasdaq under the VAXX ticker symbol. Read more... Tags: IPOs , tech ipos , upcoming ipos The post Why Vaxxinity Stock Is Not a Buy After the IPO appeared first on Money Morning - We Make Investing Profitable .
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.